Flere kvinner lever med fysiske senskader etter kirurgi og stråling i forbindelse med brystkreftbehandling. Mange trenger fysioterapibehandling.Illustrasjonsfoto: colourbox.com.
Effect of Myofascial Therapy After Surgery and Radiotherapy in Breast Cancer Treatment
Cecilie Erga, fysioterapeut, MHS, PhD kandidat, SHARE-senter for kvalitet og sikkerhet i helsetjenesten, Universitetet i Stavanger. cecilie.erga@uis.no.
Ylva Hivand Hiorth, spesialist i nevrologisk fysioterapi MNFF, PhD, Avdeling for fysikalsk medisin og rehabilitering og Senter for bevegelsesforstyrrelser, Stavanger universitetssjukehus.
Denne vitenskapelige artikkelen er fagfellevurdert etter Fysioterapeutens retningslinjer, og ble akseptert 10.januar 2025. Ingen interessekonflikter oppgitt.
Purpose: Many women experience physical late effects after surgery and radiotherapy as part of breast cancer treatment and need physiotherapy. Myofascial therapy is a commonly used treatment for these late effects, though scientific evidence is limited. This systematic review aimed to evaluate and summarize the existing research on the effects of myofascial therapy on physical late effects after breast cancer treatment with surgery and radiotherapy.
Method: Systematic literature searches for randomized controlled trials investigating the effect of myofascial therapy on late effects after breast cancer were conducted in the databases Amed, Embase, Cinahl, Medline, PEDro, and Pubmed on February 27th, 2020, and February 6th, 2023. The Cochrane Collaboration ́s tool for assessing risk of bias (RoB) was used. Meta-analyses of outcome measures on shoulder abduction and flexion (degrees), shoulder function (Disabilities of the Arm, Shoulder and Hand questionnaire, 0-100), and pain (log-transformed visual analogue scale, 0-100) were conducted to estimate mean differences with 95% confidence intervals (CIs).
Results: 233 studies were identified, of which five were included in the meta-analyses with 245 participants. Myofascial therapy improved shoulder abduction immediately after intervention (13.0; 6.3 to 19.6; p=0.001) and at last follow-up (10.4; 3.0 to 17.8; p=0.006), improved shoulder function at last follow up (-5.8; -10.7 to -1.0; p=0.020), and reduced pain intensity at last follow up (-0.33; -0.54 to -0.12; p=0.003).
Conclusion: This review indicates that myofascial therapy can have positive impact on late effects after breast cancer treatment regarding, shoulder abduction, shoulder function, and pain. More studies are needed to compare myofascial therapy with relevant alternative interventions, as well as investigating long-term effects, timing, frequency and duration of myofascial therapy, and other outcomes such as quality of life.
Key words: Breast cancer, myofascial treatment, late effects, physiotherapy.
Sammendrag
Effekt av myofascial terapi etter brystkreftbehandling
med kirurgi og stråling
Hensikt: Flere kvinner lever med fysiske senskader etter kirurgi og
stråling i forbindelse med brystkreftbehandling. Mange trenger fysioterapibehandling. Myofascial terapi er en flittig
brukt behandlingsform, men det vitenskapelige kunnskapsgrunnlaget er begrenset.
Hensikten med denne systematiske oversikten var å evaluere og sammenfatte eksisterende
forskningslitteratur om effekt av myofascial terapi på fysiske senskader etter brystkreftbehandling
med kirurgi og strålebehandling.
Design, materiale og metode: Systematiske litteratursøk etter randomiserte
kontrollerte studier om effekten
av myofascial terapi ved senskader etter brystkreft ble utført i databasene
Amed, Embase, Cinahl, Medline, PEDro og Pubmed 27. februar 2020 og 6. februar
2023. For risikovurdering av systematiske skjevheter ble The Cochrane Collaboration
́s tool for assessing risk of bias (RoB) anvendt. Metaanalyser av utfallsmålene skulderabduksjon
og skulderfleksjon (grader), skulderfunksjon (Disabilities of the Arm, Shoulder
and Hand questionnaire, 0-100), og smerte (log-transformert visual analog
scale, 0-100) ble utført for å estimere gjennomsnittlige forskjeller med 95 %
konfidensintervall.
Resultater: 233 artikler ble identifisert, hvorav
fem ble inkludert i metaanalysene med 245 deltakere. Resultatene viser at myofascial terapi forbedret
skulderabduksjon umiddelbart etter intervensjon (13,0; 6,3 til 19,6; p=0,001) og ved siste
oppfølging (10.4; 3.0 to 17.8; p=0.006), forbedret skulderfunksjon ved siste
oppfølging (-5,8; -10,7 til -1,0; p=0,020) og reduserte smerteintensitet ved
siste oppfølging (-0.33; -0,54 til -0.12; p=0,003). Vi fant ikke at myofascial
terapi forbedret skulderfleksjon.
Konklusjon: Studien indikerer at myofascial
terapi kan ha positiv effekt på senskader etter brystkreftbehandling når det
gjelder skulderabduksjon, skulderfunksjon og smerte. Det er behov for flere
studier som sammenligner myofascial terapi med relevante kontrollintervensjoner,
samt forskning på langtidseffekt, timing, frekvens og varighet av myofascial
terapi, og studier som undersøker andre utfallsmål, eksempelvis livskvalitet.
Oversiktsartikkelen, som er basert på 245 deltagere i randomiserte kontrollerte studier, viser at myofascial terapi har
positiv effekt i behandling av fysiske senskader etter brystkreftbehandling ved
å bidra til smertereduksjon og økt skulderfunksjon gjennom økt bevegelsesgrad i abduksjon.
Artikkelen viser også at det er behov for mer forskning på
myofascial terapi og senskader etter brystkreftbehandling.
Resultatene og
implikasjoner for praksis vil kunne være av betydning for klinikere som
jobber med pasienter med senskader etter brystkreftbehandling.
Introduction
Breast cancer (BC) is the most common type of cancer in women worldwide.
Due to improvements in diagnostic and treatment methods, BC has one of the
highest survival rates among cancers (1–3). Consequentially, many women experience physical
late effects in the cancerous upper body region after surgery and radiotherapy. These
effects include skin changes, tissue adherence, lymphoedema, and nerve damage, resulting
in shoulder- and upper-limb dysfunction and persisting pain (4–9). Myofascial therapy (MFT) is a commonly used
physiotherapy modality for treating these late effects. MFT is a low load manual
treatment, where slow, sustaining pressure is applied directly or indirectly to
the areas of the skin that is restricted after radiotherapy and surgery (10). The purpose of MFT is to enhance fascia
elastic properties in the radiated- and surgically affected area, improving
conditions in tight skin and underlying soft tissue (10). While the Norwegian physiotherapy union
guidelines acknowledge MFT as complementary to exercise for late effects after
BC treatment, the current research on its effectiveness is insufficient (11), and the parameters for optimal MFT treatment
intensity, application technique, amount of manual contact, and treatment
settings are unclear (12). This systematic
review aims to investigate the evidence for MFT effectiveness in randomized
controlled trials (RCTs) for preventing, reducing late physical effects in the
affected upper body following BC treatment.
Methods
Search strategy
We systematically searched Amed,
Cinahl, Embase, Medline, PEDro and Pubmed, limiting results to English, RCTs,
human studies, and publications from 2009 onward to reflect recent advances in
BC diagnostics and treatment
(9). Population of interest was participants with BC diagnosis whose cancer
treatment involved surgery and radiotherapy. There were no limitations regarding age, gender, surgical methods,
radiation dose or -area. Intervention of interest was exclusively manual MFT treatment
of soft tissue performed in the surgical affected and radiated areas.
Comparison or outcome were not specified. Search terms and synonyms (not
specified here) were “breast cancer”, “late effects”, “surgery”, “radiotherapy”,
“myofascial therapy”, and “soft tissue”. Searches were performed by two
independent investigators (C.E. and Y.H.H.) on February 27th, 2020, and
February 6th, 2023, where the last search provided no additional studies
eligible for inclusion. We conducted hand-searches in articles retrieved
through database searches, texts and other reviews, contacted a foreign expert for
further information and searched at: https://www.crd.york.ac.uk/PROSPERO/ and https://clinicaltrials.gov/.
Study Selection and Eligibility
The selection of potential articles
was done by two independent persons (C.E. and Y.H.H.) for verification of
content and eligibility. Disagreements were solved by discussion until
consensus was reached. After database searches were completed, duplicates were
removed. Selection was firstly based on title and abstract, and final selection
was based on full text. We excluded studies if participants had
not had surgery and radiotherapy or did not receive MFT directed towards the
affected areas of the body.
Data Collection and
Analyses
The authors (C.E., I.D., Y.H.H.) compiled data from the included studies
into a table (Table 1) with information on author, year, design, setting, population,
sample size, intervention received by MFT- group and control group, outcomes,
and tools used for measuring outcomes. Meta-analyses of the effect of MFT on
selected outcome measures were performed using software Review Manager (RevMan) [Computer program] version
5.4. The Cochrane Collaboration, 2020.
The effect measure was the mean difference in outcome between treatment
and control group. Due to differences in treatment length and timing, we applied random effects meta-analyses
using the inverse variance method. Heterogeneity was assessed using the I2
statistic, which estimates the percentage of between-study heterogeneity which
can be attributed to variability in the true treatment effect and tested using
the χ2 test. P-values < 0.05 were considered statistically
significant. Skewed variables were analysed on a log transformed scale using the
method suggested by Higgins et al (13). Two separate analyses were performed for each
outcome; (1) the immediate effect after the intervention, and (2) the sustained
effect based on data from the longest follow-up assessment. Forest plots of the
estimated effect sizes and 95% confidence intervals (CIs) were used to
visualize the results, with the weight of each point estimate indicated by the
relative size of the marker.
Quality assessment
Quality assessments were conducted by two independent assessors (C.E.
and Y.H.H). Risk of bias in each study was performed using The
Cochrane Collaboration ́s tool for assessing risk of bias (RoB).
This tool assesses risk of bias within seven domains regarding randomization
and allocation of participants, blinding of participants and therapists,
adequate handling of incomplete outcome data, reports of outcome measures as
planned, and other potential risk of bias where each domain is graded as high,
low or unclear (14).
Data
availability
Data that support this study
are available from the corresponding author, (C.E.), on request.
Results
Results of the search
233 articles were identified through database
searches and one additional article (15) was identified via hand search. After removing duplicates and
screening articles for eligibility by title and abstract, ten remaining
articles was left to be fully read, and five of these (15–19) were included in the present review. We excluded six articles (20–25), that did not meet the inclusion criteria.
Studies Included
Two of the included articles
(15,17) report on different outcomes from the same study,
hence, four randomized parallel-group controlled trials were included in this
review, of which two studies (15–17) were conducted in Belgium, one (18) in Ireland, and one (19) in Spain. All studies were conducted in a natural
setting, either in a clinic or a hospital by experienced therapists performing
the treatments. Two (16,18) of the studies investigated the effect of MFT
during the participants radiotherapy treatments. Two (15,17,19) of the studies investigated effect of MFT after
the patients radiotherapy treatment was finished.
Study Characteristics
In total, 245 female participants diagnosed with breast cancer were included
in the four trials, with 124 participants receiving MFT (age 53 to 63), and 121 controls (age 51 to
55).
Interventions
The interventions are described in Table 1. All studies measured effect of MFT on physical late
effects in upper body using myofascial release (10) as technique. The treatment periods lasted from 4 to 12 weeks, where MFT
was given once a week in all studies. The sessions lasted 30 minutes in all studies, except for
one (19), where the treatment session lasted for 50
minutes. The controls in two studies (15–17) received placebo
treatment using static hand placement on upper body, controls in one study (19) received manual lymph
drainage and controls in one study (18) received no physiotherapy
treatment. The participants in two (15–17) of the studies received
standard physiotherapy in addition to MFT.
TABLE 1: Characteristics of included studies
Outcome measures
Outcome measures included shoulder
range of motion (ROM), shoulder function, and pain intensity. All studies
measured outcomes before and after the intervention period. Timing of follow up
measures ranged from one to nine months after intervention. Three studies
(15,18,19) assessed the effect of
MFT om active shoulder ROMs (abduction and flexion) and reported in degrees
(more is better). All studies used
the Disabilities of the Arm, Shoulder and Hand questionnaire (DASH) to measure
shoulder function. This scale ranges from 0-100 with higher scores signifying
poorer function. Four studies (16–19) assessed the effect of MFT on pain intensity. Three of
these studies (16,17,19) used Visual Analog Scale (VAS) as measurement tool, on a range of 0-100 with
higher scores indicating more pain. The scores from the study by Serra-Añó et
al. (19) which used VAS scale ranging 0-10, were
multiplied by ten. Subsequently, all VAS scores were log
transformed due to skewness. The study by Marshall-McKenna (18) used the McGill
Pain Questionnaire (MPQ) scored with Pain Rating Index (PRI), therefore the
results from that study were not included.
Risk of bias (RoB)
The Cochrane RoB scale highlighted issues regarding allocation
concealment, blinding, selective reporting, and other bias with all trials
judged as “unclear” or “high” RoB in at least one or more criteria.
Effects of Myofascial therapy
MFT improved
shoulder abduction by 13.0 degrees immediately after treatment (95% CI, 6.3 to 19.6; p=0.001) (Figure 1). The
results were also statistically significant at follow up, with an average
improvement of 10.4 degrees as compared with the controls (mean difference, 10.4;
95% CI, 3.0 to 17.8; p=0.006) (Figure 2). Meta-analyses
on shoulder function and pain immediately after intervention were in favor of
MFT (non-statistically significant) and had in both measures statistically
significant treatment effect at
follow up, where shoulder function improved (mean difference in DASH scores, -5.8;
95% CI, -10.7 to -1.0; p=0.020) (Figure 3), and pain intensity was reduced (mean
difference in log transformed VAS, -0.33; 95% CI, -0.54 to -0.12; p=0.003) (Figure 4). The meta-analysis on shoulder flexion both
immediately after intervention and at follow up showed non-statistically
significant effect.
FIGURE 1
Figure 1: Forest plot of comparison: Range of motion: Shoulder abduction immediately after intervention. A higher number indicates greater range of motion [degrees]. MFT, myofascial therapy, SD, standard deviation, CI, confidence interval.
FIGURE 2
Figure 2: Forest plot of comparison: Range of motion: Shoulder abduction last follow up 1-9 months after intervention. A higher number indicates greater range of motion [degrees]. MFT, myofascial therapy, SD, standard deviation, CI, confidence interval.
FIGURE 3
Figure 3: Forest plot of comparison: Shoulder function DASH (0-100), last follow up 1-9 months after intervention. A higher score indicates a greater disability. [points], MFT, myofascial therapy; SD, standard deviation; CI, confidence interval.
FIGURE 4
Figure 4: Forest plot of comparison: Pain VAS last follow up 1-9 months after intervention. A higher score indicates a higher level of pain [log transformed at 0-4.6], MFT, myofascial therapy; SD, standard deviation; CI, confidence interval.
Discussion
The objective of this systematic review was to assess
the impact of MFT on physical late effects in the upper body following surgery
and radiotherapy in BC treatment. The results, encompassing four RCTs involving
245 participants, offer some support for the clinical effectiveness of
MFT concerning specific aspects of ROM, shoulder function, and pain.
These findings are in line with previous systematic reviews examining the effect
of MFT (10,12) in postoperative
rehabilitation and exercise programs (26,27) after BC
treatment. Nevertheless, this systematic review also highlights the limited research
on the effects of MFT in this specific patient group, and the included studies demonstrate
methodological limitations. There is a need for further research to strengthen
the evidence for the effectiveness of MFT. Consequently, the discussions in
this review aim to stimulate further considerations of how these findings may impact
real-world clinical practices and suggest future research directions.
The aim of MFT
is to enhance the condition of tight skin and underlying soft tissue by improving
the elastic properties of fascia. While the term “Myofascial” relates to
the fascia surrounding muscles, MFT also influences fascia situated between
other structures. “Fascia” is the web of tissues that connect all structures in
the body, from the soft collagenous connective tissues like the innermost
intramuscular layer of the endomysium, to the denser connective tissues, such
as capsules and ligaments, and it also connects the peripheral nerves to its
surrounding structures (28). The
techniques that underlie the term “myofascial therapy,” such as “myofascial
release” (10) and
“myofascial induction” (21), have the
same purposes, but lack clarity in practical application, and therefore posing
challenges for both clinical practice and research.
Soft tissue undergoes changes during and after BC treatment due to natural
healing and inflammatory processes related to surgery and radiotherapy (29,30). Post-
operative complications such as infections and seroma could impact the
post-operative healing process and increase the chances of fibrosis and rigid
scar tissue development (31–33). However, the
included studies did not provide information on post-operative complications,
which can be considered as a methodological limitation, because knowledge about
such complications is relevant in rehabilitation. A thorough pre-rehabilitation
interview and ongoing monitoring throughout the rehabilitation period is
crucial due to the continuous soft tissue changes (34). In clinical practice, strict
standardized physiotherapy regimes are less ideal because of the risk of
overburdening the fascia and soft tissue and thereby potentially cause more
harm than good. Adjusting physiotherapy interventions to
each patient is therefore crucial.
Exercise is recommended in BC
treatment rehabilitation (11), but considerations of
intensity, duration, and timing are essential for both MFT and exercise in respect
to the patient’s treatment response. The diversity of intervention
procedures for the controls in the included studies ranged from active exercise
to local scar tissue treatment. This complicates determining the comparative effectiveness
of MFT over the controls, as both groups were exposed to potential therapeutic
interventions. Future well-designed studies with a guideline driven standard
care for controls should avoid manual treatment techniques similar to MFT, and
also describe the applied MFT techniques in detail. This may offer a more
accurate measure of MFT effects.
Nerve damage is a common
reason for upper-limb dysfunction and persisting pain post-BC treatment (35). As
mentioned initially in this paper, the purpose of MFT is to improve conditions,
not only in tight skin, but also in the surrounding
structures of the peripheral nerves.
While surgical procedures and radiotherapy undoubtedly are more refined today
than in earlier years, they still affect muscles and nerves, influencing neural
pathways, muscular activity and shoulder movement (35–37). Including
nerve- and strength tests in outcome measures in clinical trials, could contribute
in development of individual targeted treatment plans, containing exercises tailored
for neuromuscular activity, and muscle control and strength. Nerve tests should
encompass the brachial nerve, given its innervation of the surgical- and
radiotherapy affected area. Strength tests should particularly focus on muscles
such as the mm. pectoralis, serratus anterior and latissimus dorsi, with a
primary emphasis on the axillary and scapular part i.e., activity in shoulder
movement. This focus is essential, as these muscles are more susceptible to
disturbances arising from BC treatment (36–38).
This systematic review comprised only a modest number of studies, exhibiting
a varied risk of bias primarily due to poorly structured procedures in most of
the included studies (15–17,19). All studies in this systematic review initiated
interventions shortly after surgery or radiotherapy and had a relatively limited
duration. Since late effects can manifest over time, becoming pronounced months
or even years after BC treatment, a notable knowledge-gap exists regarding
investigations into the long-term effects of MFT that exceeds nine months. The optimal timing for exercise and therapy, remain uncertain. Hence, there is a critical need for recommendations
on timing, appropriate dosage, and treatment intensity of both MFT and exercise.
The potential effects of MFT as a supplementary intervention to exercise in
treating physical late effects in the affected upper body after BC treatment are
still unclear. Essential for advancing this field are high-quality
RCTs with larger participant numbers and reduced bias risk.
This study has some
strengths and limitations. The criteria for
inclusion of RCTs exclusively examining MFT, avoiding other manual techniques
in the intervention group, is a procedural strength. However, limitations, such
as the small number of studies, the varied risk of bias, not considering
baseline measures in meta-analyses and excluding other study designs such as
cross over studies, warrant caution in interpreting the results. Strengths of
this systematic review includes using Preferred Reporting Items for Systematic
Reviews and Meta-analyses and the extensive and thoroughly executed literature
searches confirming the positive effect of MFT also shown in other reviews (12,26,27).
In conclusion, this current
evidence supports the effectiveness of MFT in addressing physical late effects
after BC treatment, by increasing ROM in shoulder abduction, improving shoulder
function, and reducing pain. However, there is a need for further research to
elucidate optimal treatment parameters such as treatment timing, -frequency, intensity
and -duration both regarding MFT and exercise, explore additional outcome
measures, such as nerve function, and investigate a broader long-term effect of
MFT including life quality.
3. Stegink-Jansen CW,
Buford WL, Patterson RM, Gould LJ. Computer Simulation of Pectoralis Major
Muscle Strain to Guide Exercise Protocols for Patients After Breast Cancer
Surgery. J Orthop Sports Phys Ther [Internett]. juni
2011 [sitert 17. juni 2024];41(6):417–26. Tilgjengelig på: http://www.jospt.org/doi/10.2519/jospt.2011.3358
4. Hayes SC,
Johansson K, Stout NL, Prosnitz R, Armer JM, Gabram S, mfl. Upper-body
morbidity after breast cancer. Cancer [Internett]. 2012 [sitert 17. juni
2024];118(S8):2237–49. Tilgjengelig på: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.27467
5. Johansson K,
Ingvar C, Albertsson M, Ekdahl C. Arm Lymphoedema, Shoulder Mobility and Muscle
Strength after Breast Cancer Treatment – A Prospective 2-year Study. Adv Physiother [Internett]. mai 2001 [sitert 17. juni 2024];3(2):55–66.
Tilgjengelig på: https://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=4645231&scope=site
6. Lauridsen MC,
Overgaard M, Overgaard J, Hessov IB, Cristiansen P. Shoulder disability and
late symptoms following surgery for early breast cancer. Acta Oncol [Internett]. 1. januar 2008 [sitert 17. juni
2024];47(4):569–75. Tilgjengelig på: https://doi.org/10.1080/02841860801986627
7. Askoxylakis V, Jensen AD, Häfner MF, Fetzner L, Sterzing F, Heil J,
mfl. Simultaneous
integrated boost for adjuvant treatment of breast cancer- intensity modulated
vs. conventional radiotherapy: The IMRT-MC2 trial. BMC Cancer [Internett]. januar 2011 [sitert 17. juni
2024];11(1):249–56. Tilgjengelig på: https://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=63888511&scope=site
8. Levangie PK,
Drouin J. Magnitude of late effects of breast cancer treatments on shoulder
function: a systematic review. Breast Cancer Res Treat
[Internett]. juli 2009 [sitert 17. juni 2024];116(1):1–15. Tilgjengelig på: https://www.proquest.com/docview/212475772/abstract/1AA1083E9BE24769PQ/1
9. Riaz N, Jeen T,
Whelan TJ, Nielsen TO. Recent Advances in Optimizing Radiation Therapy
Decisions in Early Invasive Breast Cancer. Cancers
[Internett]. januar 2023 [sitert 31. mars 2023];15(4):1260. Tilgjengelig på: https://www.mdpi.com/2072-6694/15/4/1260
10. Ajimsha MS, Al-Mudahka NR, Al-Madzhar JA. Effectiveness of myofascial release:
Systematic review of randomized controlled trials. J Bodyw Mov Ther [Internett]. 1. januar 2015 [sitert 23. april
2023];19(1):102–12. Tilgjengelig på: https://www.sciencedirect.com/science/article/pii/S1360859214000862
12. Pinheiro da Silva
F, Moreira GM, Zomkowski K, Amaral de Noronha M, Flores Sperandio F. Manual
Therapy as Treatment for Chronic Musculoskeletal Pain in Female Breast Cancer
Survivors: A Systematic Review and Meta-Analysis. J Manipulative Physiol Ther [Internett]. 1. september 2019 [sitert 23.
april 2023];42(7):503–13. Tilgjengelig på: https://www.sciencedirect.com/science/article/pii/S0161475418302628
13. Higgins JPT,
White IR, Anzures-Cabrera J. Meta-analysis of skewed data: Combining results
reported on log-transformed or raw scales. Stat Med
[Internett]. 2008 [sitert 17. juni 2024];27(29):6072–92. Tilgjengelig på: https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.3427
14. Higgins J,
Savović J, Page M, Sterne J. Chapter 8: Assessing risk of bias in a randomized
trial. I: Cochrane Handbook for Systematic Reviews of Interventions version 64
[Internett]. 6. utg. Cochrane; 2023 [sitert 17. juni
2024]. Tilgjengelig på: https://training.cochrane.org/handbook/current/chapter-08
15. De Groef A, Van Kampen M, Verlvoesem N, Dieltjens E, Vos L, De
Vrieze T, mfl. Effect
of myofascial techniques for treatment of upper limb dysfunctions in breast
cancer survivors: randomized controlled trial. Support
Care Cancer [Internett]. juli 2017 [sitert 17. juni 2024];25(7):2119–27.
Tilgjengelig på: https://www.proquest.com/docview/1902403995/abstract/A96E437579284472PQ/1
16. De Groef A, Van Kampen M, Vervloesem N, De Geyter S, Christiaens
MR, Neven P, mfl. Myofascial
techniques have no additional beneficial effects to a standard physical therapy
programme for upper limb pain after breast cancer surgery: a randomized
controlled trial. Clin Rehabil [Internett]. 1. desember 2017
[sitert 17. juni 2024];31(12):1625–35. Tilgjengelig på: https://doi.org/10.1177/0269215517708605
17. De Groef A, Van Kampen M, Vervloesem N, Dieltjens E, Christiaens
MR, Neven P, mfl. Effect
of myofascial techniques for treatment of persistent arm pain after breast
cancer treatment: randomized controlled trial. Clin Rehabil. 2018;32(4):451–61.
18. Marshall-McKenna
R, Paul L, McFadyen AK, Gilmartin A, Armstrong A, Rice AM, mfl. Myofascial
release for women undergoing radiotherapy for breast cancer: A pilot study. Eur J Physiother [Internett]. 1. mars 2014 [sitert 17. juni
2024];16(1):58–64. Tilgjengelig på: https://doi.org/10.3109/21679169.2013.872184
19. Serra-Añó P, Inglés M, Bou-Catalá C, Iraola-Lliso A, Espí-López GV.
Effectiveness of
myofascial release after breast cancer surgery in women undergoing conservative
surgery and radiotherapy: a randomized controlled trial. Support Care Cancer [Internett]. juli 2019 [sitert 17. juni
2024];27(7):2633–41. Tilgjengelig på: https://www.proquest.com/docview/2137067373/abstract/E9D11FB4C1B544DAPQ/1
20.
Cantarero-Villanueva I, Fernández-Lao C, Moral-Avila R del,
Fernández-de-las-Peñas C, Feriche-Fernández-Castanys MB, Arroyo-Morales M.
Effectiveness of Core Stability Exercises and Recovery Myofascial Release
Massage on Fatigue in Breast Cancer Survivors: A Randomized Controlled Clinical
Trial. Saad B, redaktør. Evid - Based Complement
Altern Med [Internett]. 2012 [sitert 17. juni 2024];2012. Tilgjengelig på: https://www.proquest.com/docview/2060805707/abstract/8EBD7CD72EBF41CDPQ/1
21. Castro-Martín E,
Ortiz-Comino L, Gallart-Aragón T, Esteban-Moreno B, Arroyo-Morales M,
Galiano-Castillo N. Myofascial Induction Effects on Neck-Shoulder Pain in
Breast Cancer Survivors: Randomized, Single-Blind, Placebo-Controlled Crossover
Design. Arch Phys Med Rehabil [Internett]. 1. mai
2017 [sitert 17. juni 2024];98(5):832–40. Tilgjengelig på: https://www.sciencedirect.com/science/article/pii/S0003999316313132
22. Fernández-Lao C,
Cantarero-Villanueva I, Díaz-Rodríguez L, Cuesta-Vargas A i.,
Fernández-Delas-Peñas C, Arroyo-Morales M. Attitudes towards massage modify
effects of manual therapy in breast cancer survivors: a randomised clinical
trial with crossover design. Eur J Cancer Care (Engl)
[Internett]. 2012 [sitert 17. juni 2024];21(2):233–41. Tilgjengelig på: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2354.2011.01306.x
23. Fernández-Lao C,
Cantarero-Villanueva I, Díaz-Rodríguez L, Fernández-de-las-Peñas C,
Sánchez-Salado C, Arroyo-Morales M. The Influence of Patient Attitude Toward
Massage on Pressure Pain Sensitivity and Immune System after Application of
Myofascial Release in Breast Cancer Survivors: A Randomized, Controlled
Crossover Study. J Manipulative Physiol Ther [Internett]. 1.
februar 2012 [sitert 17. juni 2024];35(2):94–100. Tilgjengelig på: https://www.sciencedirect.com/science/article/pii/S0161475411002296
24. Fernández-Lao C,
Cantarero-Villanueva I, Fernández-de-las-Peñas C, del Moral-Ávila R,
Castro-Sánchez AM, Arroyo-Morales M. Effectiveness of a Multidimensional
Physical Therapy Program on Pain, Pressure Hypersensitivity, and Trigger Points
in Breast Cancer Survivors: A Randomized Controlled Clinical Trial. Clin J Pain [Internett]. februar 2012 [sitert 17. juni 2024];28(2):113.
Tilgjengelig på: https://journals.lww.com/clinicalpain/abstract/2012/02000/effectiveness_of_a_multidimensional_physical.4.aspx
25. Rangon FB, Koga
Ferreira VT, Rezende MS, Apolinário A, Ferro AP, Guirro EC de O. Ischemic
compression and kinesiotherapy on chronic myofascial pain in breast cancer
survivors. J Bodyw Mov Ther [Internett]. 1. januar 2018
[sitert 17. juni 2024];22(1):69–75. Tilgjengelig på: https://www.sciencedirect.com/science/article/pii/S136085921730092X
26. De Groef A, Van
Kampen M, Dieltjens E, Christiaens MR, Neven P, Geraerts I, mfl. Effectiveness
of Postoperative Physical Therapy for Upper-Limb Impairments After Breast
Cancer Treatment: A Systematic Review. Arch Phys Med Rehabil.
2015;96(6):1140–53.
27. McNeely ML,
Campbell K, Ospina M, Rowe BH, Dabbs K, Klassen TP, mfl. Exercise interventions
for upper‐limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev [Internett]. 2010 [sitert 23. april
2023];(6). Tilgjengelig på: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005211.pub2/abstract
29. Milliat F, François A, Isoir M, Deutsch E, Tamarat R, Tarlet G,
mfl. Influence of
Endothelial Cells on Vascular Smooth Muscle Cells Phenotype after Irradiation:
Implication in Radiation-Induced Vascular Damages. Am J Pathol [Internett]. 1. oktober 2006 [sitert 29. juni
2023];169(4):1484–95. Tilgjengelig på: https://www.sciencedirect.com/science/article/pii/S0002944010626156
31. Douay N, Akerman
G, Clément D, Malartic C, Morel O, Barranger E. Seroma after axillary lymph
node dissection in breast cancer. Gynécologie
Obstétrique Fertil [Internett]. februar 2008 [sitert 20. august
2023];36(2):130–5. Tilgjengelig på: https://linkinghub.elsevier.com/retrieve/pii/S1297958907005498
32. Lotfy WE, Mohamed
OAA, Elhady LM, Abuojaylah MA. An Overview of Post Mastectomy Seroma and
Treatment Options: Review Article. Egypt J
Hosp Med [Internett]. 1. juli 2022 [sitert 20. august 2023];88(1):2568–70.
Tilgjengelig på: https://ejhm.journals.ekb.eg/article_239192.html
33. Kim S, Kim YS.
Radiation-induced osteoradionecrosis of the ribs in a patient with breast
cancer: A case report. Radiol Case Rep [Internett]. 1. august 2022
[sitert 20. august 2023];17(8):2894–8. Tilgjengelig på: https://www.sciencedirect.com/science/article/pii/S193004332200067X
34. Borrelli MR, Shen
AH, Lee GK, Momeni A, Longaker MT, Wan DC. Radiation-induced skin fibrosis:
pathogenesis, current treatment options, and emerging therapeutics. Ann Plast Surg [Internett]. oktober 2019 [sitert 23. april
2023];83(4):S59–64. Tilgjengelig på: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746243/
35. Joshi D, Shah S,
Shinde SB, Patil S. Effect of Neural Tissue Mobilization on Sensory-Motor
Impairments in Breast Cancer Survivors with Lymphedema: An Experimental Study.
Asian Pac J Cancer Prev APJCP. 1. januar 2023;24(1):313–9.
36. Rasmussen GHF,
Kristiansen M, Arroyo-Morales M, Voigt M, Madeleine P. Absolute and relative
reliability of pain sensitivity and functional outcomes of the affected
shoulder among women with pain after breast cancer treatment. PLoS One [Internett]. juni 2020 [sitert 26. juni 2023];15(6):e0234118.
Tilgjengelig på: https://www.proquest.com/docview/2409182283/abstract/4AEB7FE699C3483EPQ/1
37. Leonardis JM, Lulic-Kuryllo T, Lipps DB. The impact of local therapies for breast
cancer on shoulder muscle health and function. Crit Rev
Oncol Hematol [Internett]. september 2022 [sitert 22. august 2023];177:103759.
Tilgjengelig på: https://linkinghub.elsevier.com/retrieve/pii/S1040842822001834
38. Paolucci T,
Capobianco SV, Bai AV, Bonifacino A, Agostini F, Bernetti A, mfl. The reaching
movement in breast cancer survivors: Attention to the principles of
rehabilitation. J Bodyw Mov Ther [Internett]. oktober 2020
[sitert 21. juni 2023];24(4):102–8. Tilgjengelig på: https://linkinghub.elsevier.com/retrieve/pii/S1360859220301182